Structure of the p53 tumor suppressor bound to the ankyrin and SH3 domains of 53BP2 Journal Article


Authors: Gorina, S.; Pavletich, N. P.
Article Title: Structure of the p53 tumor suppressor bound to the ankyrin and SH3 domains of 53BP2
Abstract: Mutations in the p53 tumor suppressor are among the most frequently observed genetic alterations in human cancer and map to the 200-amino acid core domain of the protein. The core domain contains the sequence-specific DNA binding activity and the in vitro 53BP2 protein binding activity of p53. The crystal structure of the p53 core domain bound to the 53BP2 protein, which contains an SH3 (Src homology 3) domain and four ankyrin repeats, revealed that (i) the SH3 domain binds the L3 loop of p53 in a manner distinct from that of previously characterized SH3-polyproline peptide complexes, and (ii) an ankyrin repeat, which forms an L-shaped structure consisting of a β hairpin and two α helices, binds the L2 loop of p53. The structure of the complex shows that the 53BP2 binding site on the p53 core domain consists of evolutionarily conserved regions that are frequently mutated in cancer and that it overlaps the site of DNA binding. The six most frequently observed p53 mutations disrupt 53BP2 binding in vitro. The structure provides evidence that the 53BP2-p53 complex forms in vivo and may have a critical role in the p53 pathway of tumor suppression. Mutations in the p53 tumor suppressor are among the most frequently observed genetic alterations in human cancer and map to the 200-amino acid core domain of the protein. The core domain contains the sequence-specific DNA binding activity and the in vitro 53BP2 protein binding activity of p53. The crystal structure of the p53 core domain bound to the 53BP2 protein, which contains an SH3 (Src homology 3) domain and four ankyrin repeats, revealed that (i) the SH3 domain binds the L3 loop of p53 in a manner distinct from that of previously characterized SH3-polyproline peptide complexes, and (ii) an ankyrin repeat, which forms an L-shaped structure consisting of a β hairpin and two α helices, binds the L2 loop of p53. The structure of the complex shows that the 53BP2 binding site on the p53 core domain consists of evolutionarily conserved regions that are frequently mutated in cancer and that it overlaps the site of DNA binding. The six most frequently observed p53 mutations disrupt 53BP2 binding in vitro. The structure provides evidence that the 53BP2-p53 complex forms in vivo and may have a critical role in the p53 pathway of tumor suppression.
Keywords: controlled study; gene mutation; mutation; protein conformation; neoplasms; proteins; dna damage; enzyme inhibition; genes; protein dna binding; protein protein interaction; protein binding; enzyme inhibitor; peptide; oncology; protein p53; carcinogenesis; tumor suppressor gene; dna; amino acid sequence; molecular sequence data; recombinant fusion proteins; carrier proteins; tumor suppressor protein p53; binding protein; crystal structure; hydrogen bonding; models, molecular; crystallography, x-ray; protein structure, tertiary; binding sites; tumor suppressor; amino acids; protein folding; protein structure; dna binding; protein structure, secondary; diseases; tumor suppression; mutations; cells; ankyrins; ankyrin; humans; human; priority journal; article; src homology domains
Journal Title: Science
Volume: 274
Issue: 5289
ISSN: 0036-8075
Publisher: American Association for the Advancement of Science  
Date Published: 1996-11-08
Start Page: 1001
End Page: 1005
Language: English
DOI: 10.1126/science.274.5289.1001
PUBMED: 8875926
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 22 November 2017 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Svetlana V Gorina
    4 Gorina